IRIS
PESCE, GIAMPAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.572
AS - Asia 31
SA - Sud America 9
NA - Nord America 1
Totale 11.613
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.572
CN - Cina 22
BR - Brasile 8
SG - Singapore 5
VN - Vietnam 2
ID - Indonesia 1
IQ - Iraq 1
PE - Perù 1
US - Stati Uniti d'America 1
Totale 11.613
Salva come PNG Salva come JPEG
Città #
Genova 6.846
Genoa 2.929
Rapallo 940
Vado Ligure 845
Bordighera 12
Beijing 8
Singapore 4
Campo Belo 1
Cupira 1
Goioerê 1
Hanoi 1
Ho Chi Minh City 1
Indaiatuba 1
Juiz de Fora 1
Lima 1
Londrina 1
Matinhos 1
Muhafazat Babil 1
New York 1
Querência 1
Semarang 1
Totale 11.598
Salva come PNG Salva come JPEG
Nome #
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 192
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 178
Adhesion molecules in allergy. 177
Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. 175
Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference 159
Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation 159
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets 158
B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. 156
Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection 155
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury 148
Estimate of the Prevalence of Anti-Gastric Parietal Cell Autoantibodies in Healthy Individuals Is Method Dependent 145
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. 145
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 144
Unexpected elevated free thyroid hormones in pregnancy 144
Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva allergen challenge. 140
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 140
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 140
The management of the patient with unexpected autoantibody positivity 136
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 136
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 136
Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy 135
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 133
BT3 molecules ligation enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 132
Effects of conjunctival hyperosmolar challenge in allergic subjects and normal controls. 132
Cetirizine does not influence the immune response. 131
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 131
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 130
THE SOLUBLE FORM OF CTLA-4 FROM SERUM OF PATIENTS WITH AUTOIMMUNE DISEASES REGULATES T-CELL RESPONSES. 128
Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods. 128
The adhesion molecules of allergic inflammation: recent insights into their functional roles. 127
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro 127
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 126
Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines 123
Co-stimulatory molecules in Graves' disease 122
Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test. 122
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 121
SERUM LAIR-2 IS INCREASED IN AUTOIMMUNE THYROID DISEASES 121
The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes. 119
Tocilizumab in MOG-antibody spectrum disorder: a case report 118
In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation 116
Oversecretion of soluble CTLA-4 in various autoimmune diseases overlapping celiac disease. 116
High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. 116
Occurrence of overt celiac disease in the elderly following total thyroidectomy 115
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity. 115
Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease 115
Intraepithelial gamma/delta T-cells and intestinal villous atrophy. 114
Population screening for coeliac disease in a low prevalence area in Italy 114
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 114
Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease 111
Expression of very late activation antigen-1 on intrathyroid lymphocytes in autoimmune thyroid disease. 111
Protective effect of loratadine on specific conjunctival provocation test. 110
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics 110
Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation. 109
Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis 108
Stress and autoimmune thyroid diseases 107
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update 107
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury and tissue-transglutaminase antibody production. 105
Costimulatory molecules and autoimmune thyroid diseases 103
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 102
Follicular thyroid cells of autoimmune thyroiditis may coexpress [CAM1 (CD54) and its natural ligand LFA1 (CDlla/CD18) 101
«ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation» 101
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 100
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection 100
Protective effects of deflazacort on allergen-specific conjunctival challenge. 99
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 98
“IgA antiendomyisium antibodies in human umbilical cord sections as a screening test in relatives of patients with celiac disease” Allergy 52: 1017-21, 1997 97
Use of an artificial neural network to predict Graves\' disease outcome within 2 years of drug withdrawal 96
Diagnostics of dysimmune peripheral neuropathies 95
Sensitization to food or inhalant allergens in pediatric patients. Clinical usefulness of first-level panel tests for specific IgE 94
Pharmacokinetics of Der P 2 allergen and derived monomeric allergoid in allergic volunteers 93
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 93
Functional involvement of LFA/ICAM1 adhesion system in the autologous mixed lymphocyte reaction Cell 90
Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with b7.1 costimulatory molecule-Comment 89
NERVE ULTRASOUND AND 3-TESLA MAGNETIC RESONANCE IMAGING FINDINGS IN NODO-PARANODOPATHIES: CORRELATION WITH CLINICAL AND NEUROPHYSIOLOGICAL EXAMINATIONS 88
Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. 88
Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association 87
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 86
Autoimmune thyroid disease: immunological model and clinical problem 85
“Possible pathogenetical relevance of Interleukin-1b in “destuctive” organ-specific autoimmune disease (Hashimoto’s thyroiditis)”. 81
Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. 76
Molecular events in allergc inflammation: experimental evidence and possible modulation. 75
Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects. 74
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. 74
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 73
I recettori BT3, membri della famiglia B7, aumentano la risposta proinfiammatoria dei monociti e della cellule dendritiche umane. 73
«ICAM-1/ CD54 expression on conjunctival epithelium during pollen season» 72
Molecole di adesione: struttura, funzione e ruolo fisiopatologico nelle malattie infiammatorie 72
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 72
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update 71
Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount. 70
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 70
La diagnostica delle malattie autoimmuni 69
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 67
La forma solubile di CTLA-4 è espressa nel siero di pazienti pediatrici affetti da leucemia linfoblastica acuta. 65
Papillary thyroid cancer:phenotypic analysis of infiltrating T lymphocytes 64
FISIOPATOLOGIA E BASI GENETICHE DELL'AUTOIMMUNITA' SISTEMICA 62
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 62
EPIDEMIOLOGIA DELLE MALATTIE AUTOIMMUNI ORGANO-SPECIFICHE 58
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays. 56
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 56
Totale 10.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.240
article - articoli 37.166
book - libri 0
conference - conferenze 804
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.270
Totale 78.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021600 0 0 0 79 62 45 41 79 79 93 73 49
2021/20221.309 27 91 88 133 77 84 81 293 62 126 68 179
2022/20231.163 116 82 12 115 158 228 37 82 206 9 98 20
2023/2024627 33 84 33 90 48 108 26 35 38 8 25 99
2024/20252.039 53 144 86 136 289 215 246 290 71 122 165 222
2025/20261.006 399 123 237 247 0 0 0 0 0 0 0 0
Totale 11.813